Manulife (Manufacturers Life Insurance)
ATNM icon

Manulife (Manufacturers Life Insurance)’s Actinium Pharmaceuticals ATNM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,488
Closed -$92.4K – 3001
2024
Q2 		$92.4K Buy
+12,488
New +$103K ﹤0.01% 2843
2023
Q4 		– Sell
-11,177
Closed -$66.2K – 2959
2023
Q3 		$66.2K Hold
11,177
– – ﹤0.01% 2906
2023
Q2 		$82.9K Buy
+11,177
New +$95.1K ﹤0.01% 2907
2015
Q2 		– Sell
-186
Closed -$14 – 4023
2015
Q1 		$14 Sell
186
-323
-63% -$38.4K ﹤0.01% 3509
2014
Q4 		$90 Buy
509
+42
+9% +$7.97K ﹤0.01% 3093
2014
Q3 		$94 Buy
+467
New +$92.6K ﹤0.01% 3125

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ATNM Position: Q3 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Actinium Pharmaceuticals (ATNM) in Q3 2024, closing a stake of 12,488 shares — an estimated $92.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ATNM in Q3 2014 and held it in 6 quarters. The position peaked at $92.4K in Q2 2024. 72 funds tracked by Wall St. Rank hold ATNM as of Q3 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Actinium Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 12,488 Actinium Pharmaceuticals shares in Q3 2024, an estimated $92.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Actinium Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s Actinium Pharmaceuticals position peaked at $92.4K in Q2 2024.
  • 72 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2024, filed 13 Nov 2024.